Adrian Hargrave, CEO of SEEEN, explains how the Company is now funded through to profitability.  Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMCS.L Regulatory News (MCS)

  • There is currently no data for MCS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

2 May 2017 08:26

RNS Number : 8612D
McCarthy & Stone PLC
02 May 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached:

McCarthy & Stone plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

 

X

 

Other (please specify):

3. Full name of person(s) subject to thenotification obligation:

The Goldman Sachs Group, Inc.

4. Full name of shareholder(s)  (if different from 3.):

Goldman Sachs International

ELQ Investors VIII Ltd

5. Date of the transaction and date onwhich the threshold is crossed orreached:

26 April 2017

6. Date on which issuer notified:

28 April 2017

7. Threshold(s) that is/are crossed orreached:

N/A

 

 

 

 

 

 

 

 

 

 

 

 

 

8. Notified details:

A: Voting rights attached to shares

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

 

GB00BYNVD082

10,162,005

10,162,005

34,029,761

6.33%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate

Exercise/Conversion Period

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial instrument

Exercise price

Expiration date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

Nominal

Delta

Please refer to Annexure A

 

 

3,197,076

0.60%

 

 

Total (A+B+C)

Number of voting rights

 

Percentage of voting rights

37,226,837

6.93%

 

 

 

 

 

 

 

 

 

 

 

 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable:

 

The Goldman Sachs Group, Inc.; 37,226,837 shares; 6.93%

 

Goldman Sachs (UK) L.L.C. (Controlled by The Goldman Sachs Group, Inc.); 27,226,837 shares; 5.03%

Goldman Sachs Group UK Limited (Controlled by Goldman Sachs (UK) L.L.C.); 27,226,837 shares; 5.03%

Goldman Sachs International (Controlled by Goldman Sachs Group UK Limited); 27,226,837 shares; 5.03%

 

Goldman Sachs (UK) L.L.C. (Controlled by The Goldman Sachs Group, Inc.)

Goldman Sachs Group UK Limited (Controlled by Goldman Sachs (UK) L.L.C.)

Goldman Sachs Group Holdings (U.K.) Limited (Controlled by Goldman Sachs Group UK Limited)

ELQ Investors VIII Ltd (Controlled by Goldman Sachs Group Holdings (U.K.) Limited)

 

Proxy Voting:

10. Name of the proxy holder:

 

N/A

11. Number of voting rights proxy holder will ceaseto hold:

 

N/A

12. Date on which proxy holder will cease to holdvoting rights:

N/A

 

 

13. Additional information:

Please note, total amount of voting rights have been rounded to 2 decimal places therefore there is a possibility of a rounding error.

 

General email contact:

shareholderdisclosures@gs.com

 

14. Contact name:

Joanna Foley

15. Contact telephone number:

+44 207 051 9996

 

 

 

 

 

 

 

 

 

 

Annexure A

Attached to notification of voting rights given in fulfilment of the obligations imposed by the FCA in accordance with DTR5 (including section 5.8.1). by The Goldman Sachs Group, Inc. dated 26 April 2017 for itself and its subsidiaries in relation to McCarthy & Stone plc

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

Nominal

Delta

CFD

13-Aug-2026

417,011

0.08%

CFD

25-Nov-2026

1,415,367

0.26%

CFD

25-Nov-2026

226,088

0.04%

CFD

25-Nov-2026

119,480

0.02%

CFD

9-Dec-2026

288,456

0.05%

CFD

24-Feb-2027

23,627

0.004%

CFD

3-Mar-2027

164,930

0.03%

Swap

19-Mar-2018

2,400

0.0004%

CFD

7-Apr-2027

37,501

0.0070%

CFD

8-Apr-2027

73,901

0.01%

Swap

18-Apr-2018

4,900

0.001%

Swap

18-Apr-2018

3,700

0.001%

Swap

18-Apr-2018

5,800

0.001%

Swap

18-Apr-2018

33,600

0.006%

CFD

14-Apr-2027

12,519

0.002%

Swap

18-Apr-2018

1,600

0.0003%

Swap

18-Apr-2018

2,100

0.0004%

Swap

18-Apr-2018

3,300

0.0006%

Swap

17-May-2018

6,500

0.001%

Swap

17-May-2018

10,100

0.002%

Swap

17-May-2018

13,200

0.002%

Swap

17-May-2018

20,700

0.004%

Swap

17-May-2018

6,500

0.001%

Swap

17-May-2018

10,200

0.002%

CFD

25-Apr-2018

2,095

0.0004%

CFD

28-Apr-2027

291,501

0.05%

Total Number of voting rights and percentage of voting rights

3,197,076

0.60%

Additional information: Please note, total amount of voting rights have been rounded to 2 decimal places therefore there is a possibility of a rounding error.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUUUBRBOAVRRR
Date   Source Headline
31st Jul 20208:23 amRNSDirectorate Change
29th Jul 20205:41 pmRNSHolding(s) in Company
15th Jul 20207:01 amRNSDirectorate Change
15th Jul 20207:00 amRNSHalf Year Results
3rd Jul 20209:00 amRNSNotice of Interim Results
22nd Jun 20204:11 pmRNSHolding(s) in Company
9th Jun 20204:18 pmRNSHolding(s) in Company
2nd Jun 20207:00 amRNSCOVID-19 Business Update
1st Jun 20209:30 amRNSDirector/PDMR Shareholding
28th May 202012:13 pmRNSDirector/PDMR Shareholding
19th May 20201:11 pmRNSDirector/PDMR Shareholding
12th May 20207:00 amRNSDirectorate Change
1st May 20207:00 amRNSTotal Voting Rights
1st May 20207:00 amRNSHolding(s) in Company
30th Apr 20205:56 pmRNSSale of assets to Waverstone LLP
29th Apr 20203:50 pmRNSDisclosure of Rights Attached to Equity Shares
7th Apr 202011:41 amRNSAdditional Listing
2nd Apr 20204:28 pmRNSDirector/PDMR Shareholding
27th Mar 20202:37 pmRNSHolding(s) in Company
25th Mar 202011:14 amRNSResults of Annual General Meeting
25th Mar 20207:00 amRNSAGM & Business Update
24th Mar 20201:37 pmRNSHolding(s) in Company
20th Mar 20204:17 pmRNSAnnual General Meeting and Covid-19
18th Mar 20204:42 pmRNSSecond Price Monitoring Extn
18th Mar 20204:37 pmRNSPrice Monitoring Extension
18th Mar 202010:56 amRNSCOVID-19 update
12th Mar 202011:44 amRNSHolding(s) in Company
2nd Mar 20209:14 amRNSTotal Voting Rights
19th Feb 202010:03 amRNSAnnual Financial Report
11th Feb 202010:22 amRNSDirector/PDMR Shareholding
7th Feb 20208:32 amRNSDirector/PDMR Shareholding
3rd Feb 20201:50 pmRNSHolding(s) in Company
3rd Feb 20209:16 amRNSBlock listing Interim Review
3rd Feb 20209:04 amRNSTotal Voting Rights
29th Jan 20203:45 pmRNSHolding(s) in Company
28th Jan 20207:00 amRNSFull Year Results
15th Jan 202010:40 amRNSDirector Declaration
13th Jan 20207:00 amRNSNotice of Results
10th Jan 20207:00 amRNSAppointment - General Counsel & Company Secretary
9th Jan 20202:35 pmRNSHolding(s) in Company
2nd Jan 202010:30 amRNSTotal Voting Rights
12th Dec 20199:12 amRNSDirectorate Change
15th Nov 20198:55 amRNSDirector/PDMR Shareholding
14th Nov 20198:06 amRNSHolding(s) in Company
13th Nov 20193:09 pmRNSHolding(s) in Company
7th Nov 20199:09 amRNSHolding(s) in Company
7th Nov 20197:00 amRNSFY19 Trading Update
1st Nov 20198:27 amRNSDirectorate Change
24th Oct 20198:05 amRNSHolding(s) in Company
22nd Oct 20193:17 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.